Analysis of Minimally Invasive Left Thoracotomy HVAD Implantation - A Single-Center Experience.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 29 5 2018
medline: 29 5 2019
entrez: 28 5 2018
Statut: ppublish

Résumé

Minimally invasive left ventricular assist device (LVAD) implantation may reduce peri-/postoperative complications and risks associated with resternotomies. In this study, we describe our first results using a minimally invasive LVAD implantation technique (lateral thoracotomy [LT] group). These results were compared with LVAD implantations done via full median sternotomy (STX group). HVAD (HeartWare, Framingham, Massachusetts, United States) implantations in 70 patients (LT group No survival differences were observed between the LT and STX group ( The minimally invasive approach is a viable alternative with the possibility to reduce complications and should be particularly considered for bridge-to-transplant patients.

Sections du résumé

BACKGROUND
Minimally invasive left ventricular assist device (LVAD) implantation may reduce peri-/postoperative complications and risks associated with resternotomies. In this study, we describe our first results using a minimally invasive LVAD implantation technique (lateral thoracotomy [LT] group). These results were compared with LVAD implantations done via full median sternotomy (STX group).
METHODS
HVAD (HeartWare, Framingham, Massachusetts, United States) implantations in 70 patients (LT group
RESULTS
No survival differences were observed between the LT and STX group (
CONCLUSION
The minimally invasive approach is a viable alternative with the possibility to reduce complications and should be particularly considered for bridge-to-transplant patients.

Identifiants

pubmed: 29804285
doi: 10.1055/s-0038-1649493
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

170-175

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Auteurs

D Reichart (D)

Department of General and Interventional Cardiology, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

C F Brand (CF)

Department of Cardiovascular Surgery, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

A M Bernhardt (AM)

Department of Cardiovascular Surgery, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

S Schmidt (S)

Department of General and Interventional Cardiology, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

A Schaefer (A)

Department of Cardiovascular Surgery, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

S Blankenberg (S)

Department of General and Interventional Cardiology, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

H Reichenspurner (H)

Department of Cardiovascular Surgery, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

F M Wagner (FM)

Department of Cardiovascular Surgery, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

T Deuse (T)

Department of Cardiovascular Surgery, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

M J Barten (MJ)

Department of Cardiovascular Surgery, University Heart Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH